Legalizing cannabis could earn the UK £1.5 billion a year
A recent report by the British foundation Transform highlights the economic benefits that the United Kingdom could benefit from the legalization and regulation of the Cannabis.
The study estimates that such a measure could generate 1.5 billion pounds sterling per year, by combining 1 billion pounds in tax revenue and 300 million pounds in savings on costs related to law enforcement, the courts, and incarceration.
Beyond the tax benefits, legalization could create more 15,500 full-time jobs, while significantly reducing the illegal cannabis market.
As stated by Steve Rolles, a senior policy analyst at Transform, said, «There are many compelling arguments for ending the generational failure and injustice of cannabis prohibition, but economic arguments carry particular weight in the current political debate.».
https://twitter.com/TransformDrugs/status/1896862232996360609
Three Models of Legalization
The report explores three distinct regulatory approaches :
- A state-controlled business model: This model, which is similar to the Canadian system, would maximize revenue, potentially bringing in 1.23 billion pounds sterling in tax revenue while saving money 284 million pounds sterling in criminal justice costs. However, it raises concerns about the market consolidation and corporate dominance
- A nonprofit home-based farming model: Inspired by the’Spain, Uruguay, Germany, and Malta, this approach would result in 345 million pounds of tax revenue and would create 7,000 jobs. Although it would help reduce regulatory costs and prevent corporate influence, it would likely only replace 45% from the black market
- A hybrid model: This strategy combines the home cultivation, nonprofit cannabis organizations, and regulated retail sales. It is expected to bring in 1.1 billion pounds sterling tax revenue and create 15,525 jobs, while taking hold of 80% on the black market within five years. If this model reconciles the economic benefits and public health safeguards, it nonetheless carries risks of market monopoly
Social and Public Health Considerations
While the report emphasizes the economic benefits, it stresses that these should not overshadow the priorities in public health and social justice. Legalization would allow the sale of safer, lab-tested cannabis products, would ensure a clear control of the dosage and would shift the focus from criminal penalties to risk reduction and education.
According to Ester Kincová, a co-author of the report, said, «Making cannabis illegal has been a generational failure; it has undermined public health, criminalized millions of people, wasted taxpayer money, and is becoming increasingly unpopular with the public.».
In addition, the report calls for measures to address the historical injustices of cannabis prohibition, which have disproportionately affected the marginalized communities, in particular the Black population. A legalized market could lead to a Targeted reinvestment of cannabis revenue and theexpungement of past convictions, thereby providing better opportunities for those who were affected by previous policies.
Despite a global trend toward cannabis regulation, the British government has not yet begun serious discussions on reform. As stated by Steve Rolles, «It is high time for the British government to grow up—to face reality—and to begin a mature debate on how the legalization and regulation of cannabis could benefit the United Kingdom.».
-
Cannabis in France3 weeks ago
France Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Cannabis in Europe2 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Business4 weeks ago
Eight years after legalization, South African cannabis is still waiting for its legal market
-
Cannabis in France4 weeks ago
French Prime Minister Calls for Drug Testing in Government Ministries
-
Cannabis in Ukraine4 weeks ago
Ukraine Issues Its First Medical Cannabis Prescriptions to Veterans
-
Business3 weeks ago
Sanity Group is expanding its presence in Switzerland through a distribution agreement with Astrasana
-
Cannabis in the U.S.2 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Cannabis in Ireland2 weeks ago
The Irish Parliament recommends decriminalizing all drugs


You must be logged in to post a comment Login